Thyroid cancer is the most common cancer diagnosis among those aged 15-29, with a noticeable increase in cases over the last decade. YouTube, one of the most frequented websites on the internet, serves as a common platform to obtain health information. This study uses a systematic approach to characterize YouTube videos related to radioactive iodine (RAI) therapy for thyroid cancer. The first 50 videos across four distinct YouTube search terms related to RAI therapy for thyroid cancer were identified after applying exclusion criteria. A previously validated video assessment tool was utilized to evaluate the videos. Two independent reviewers assessed a random sample of 10 videos, while the remaining 40 videos were evaluated by one reviewer as there were minimal discrepancies in coding. Among the identified videos, 26 videos were published within the past 3 years, with a median video length of 4 min and 53s. The three most common publishers' affiliations were non-profits (15 videos), personal accounts (12 videos), and health care facilities/organizations (11 videos). Most of the videos originated in the United States, used an interview format, featured physician presenters, and were directed towards patients. Highly covered topics included "side effects and risks" and "RAI therapy overview". The findings underscore the significant role YouTube plays in aiding patient comprehension of RAI therapy for thyroid cancer based on video parameters and content. These results can inform physicians' discussions with patients regarding YouTube and contribute to the development of new, high-quality YouTube videos to support thyroid cancer education.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s13187-024-02531-9 | DOI Listing |
Eur J Nucl Med Mol Imaging
January 2025
Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, 1838 Guangzhou North Road, Guangzhou, China.
Purpose: To explore the dynamic and parametric characteristics of [F]F-FAPI-42 PET/CT in lung cancers.
Methods: Nineteen participants with newly diagnosed lung cancer underwent 60-min dynamic [F]F-FAPI-42 PET/CT. Time-activity curves (TAC) were generated for tumors and normal organs, with kinetic parameters (K, K, K, K, K) calculated.
Int J Gen Med
December 2024
Department of Internal Medicine, Chungbuk National University College of Medicine and Chungbuk National University Hospital, Cheongju, South Korea.
Purpose: Papillary thyroid carcinoma (PTC) is the most common thyroid malignancy. Although its mortality rate is low, some patients experience cancer recurrence during follow-up. In this study, we investigated the accuracy of a novel multimodal model by simultaneously analyzing numeric and time-series data to predict recurrence in patients with PTC after thyroidectomy.
View Article and Find Full Text PDFFront Immunol
December 2024
Department of Oncology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Liver cancer remains one of the most formidable challenges in modern medicine, characterized by its high incidence and mortality rate. Emerging evidence underscores the critical roles of the immune microenvironment in tumor initiation, development, prognosis, and therapeutic responsiveness. However, the composition of the immune microenvironment of liver cancer (LC-IME) and its association with clinicopathological significance remain unelucidated.
View Article and Find Full Text PDFJ Surg Case Rep
January 2025
Department of Breast and Thyroid Surgery, Aizawa Hospital, 2-5-1 Honjo, Matsumoto, Nagano 390-8510, Japan.
The use of video-assisted thoracic surgery (VATS) has increased in recent years. We herein report a case wherein suspected intramammary lymph node (IM) recurrence of breast cancer was treated using the thoracic approach (VATS). A 53-year-old woman had undergone right total mastectomy, axillary lymph node dissection, and implant-based reconstruction for right breast cancer 19 years ago.
View Article and Find Full Text PDFCancer Diagn Progn
January 2025
Department of Head and Neck Surgery, Iwate Medical University School of Medicine, Yahaba, Japan.
Background/aim: The role of lenvatinib as neoadjuvant chemotherapy for patients with advanced thyroid cancer has not been firmly established. In some cases, surgery may be considered when lenvatinib treatment becomes challenging to continue.
Case Report: We present four cases of unresectable thyroid cancer diagnosed histologically as papillary carcinoma.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!